{
    "2021-10-28": [
        [
            {
                "time": "2021-11-28",
                "original_text": "在李佳琦的直播间里，看不到华熙生物的未来",
                "features": {
                    "keywords": [
                        "李佳琦",
                        "直播间",
                        "华熙生物",
                        "未来"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "美妆",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-28",
                "original_text": "最高预售量69万+，双十一国牌美妆大卖，背后受益公司是谁？",
                "features": {
                    "keywords": [
                        "预售量",
                        "双十一",
                        "国牌美妆",
                        "受益公司"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "美妆"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-28",
                "original_text": "A股资金流向：周期股下挫，新能源板块出现剧烈分歧",
                "features": {
                    "keywords": [
                        "A股",
                        "资金流向",
                        "周期股",
                        "新能源板块"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源",
                        "周期股"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-28",
                "original_text": "受高额营销费拖累，华熙生物三季度净利增速放缓至14％ 盈利能力下降",
                "features": {
                    "keywords": [
                        "高额营销费",
                        "华熙生物",
                        "净利增速",
                        "盈利能力"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-28",
                "original_text": "信达证券维持华熙生物买入评级：功能性化妆品持续高增，原料业务加速",
                "features": {
                    "keywords": [
                        "信达证券",
                        "华熙生物",
                        "功能性化妆品",
                        "原料业务"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "化妆品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-28",
                "original_text": "国元证券维持华熙生物买入评级：收入持续高速增长，四大业务板块协同发展",
                "features": {
                    "keywords": [
                        "国元证券",
                        "华熙生物",
                        "收入增长",
                        "业务板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-28",
                "original_text": "东吴证券维持华熙生物买入评级：营收保持高增，功能性护肤主要品牌费用率趋于改善",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "华熙生物",
                        "营收",
                        "功能性护肤"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "护肤品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-28",
                "original_text": "华熙生物前三季度1.92亿元研发费用，传递出什么关键信息？",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "研发费用",
                        "关键信息"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-28",
                "original_text": "东方财富证券维持华熙生物增持评级，2021年三季报点评：功能护肤品收入大幅增长",
                "features": {
                    "keywords": [
                        "东方财富证券",
                        "华熙生物",
                        "功能护肤品",
                        "收入增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "护肤品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-28",
                "original_text": "华熙生物（688363）：前端运营良好，费用侵蚀业绩，长逻辑不变",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "前端运营",
                        "费用侵蚀",
                        "业绩"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}